Siga Technologies (SIGA) Assets Average (2011 - 2025)
Siga Technologies' (SIGA) quarterly Assets Average came in at $225.5 million in Q4 2025, up 2.59% on a YoY basis from $219.8 million in Q4 2024, and down 3.4% quarter-over-quarter from $233.5 million in Q3 2025.
Analysis
Siga Technologies (SIGA) Assets Average (2011 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Assets Average for 15 consecutive years, with $225.5 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Assets Average rose 2.59% year-over-year to $225.5 million; the trailing twelve-month figure through Dec 2025 stood at $225.5 million (up 2.59% YoY), and the FY2025 full-year result was $231.9 million, down 7.0% from the prior year.
- Assets Average declined to $225.5 million in Q4 2025 per SIGA's latest filing, from $233.5 million in the prior quarter.
- Across five years, Assets Average topped out at $248.7 million in Q1 2024 and bottomed at $134.6 million in Q3 2021.
- Historically, Assets Average has averaged $194.2 million across 5 years, with a median of $196.8 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Assets Average jumped 38.35% in 2022, then retreated 16.28% in 2023.
- Over 5 years, Assets Average stood at $175.1 million in 2021, then grew by 13.98% to $199.6 million in 2022, then climbed by 3.37% to $206.4 million in 2023, then climbed by 6.53% to $219.8 million in 2024, then increased by 2.59% to $225.5 million in 2025.
- According to Business Quant data, Assets Average over the past three periods registered $225.5 million, $233.5 million, and $241.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 200.98 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 135.79 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 129.24 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 120.28 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 204.57 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 149.95 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 3.29 Bn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 7.61 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 6.97 Bn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | 225.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 225.54 Mn |
| Sep 30, 2025 | 233.47 Mn |
| Jun 30, 2025 | 241.20 Mn |
| Mar 31, 2025 | 245.70 Mn |
| Dec 31, 2024 | 219.85 Mn |
| Sep 30, 2024 | 194.01 Mn |
| Jun 30, 2024 | 217.90 Mn |
| Mar 31, 2024 | 248.75 Mn |
| Dec 31, 2023 | 206.37 Mn |
| Sep 30, 2023 | 152.45 Mn |
| Jun 30, 2023 | 165.22 Mn |
| Mar 31, 2023 | 189.48 Mn |
| Dec 31, 2022 | 199.63 Mn |
| Sep 30, 2022 | 182.08 Mn |
| Jun 30, 2022 | 172.24 Mn |
| Mar 31, 2022 | 199.64 Mn |
| Dec 31, 2021 | 175.14 Mn |
| Sep 30, 2021 | 134.62 Mn |
| Jun 30, 2021 | 136.23 Mn |
| Mar 31, 2021 | 144.30 Mn |